Phibro Animal Health Corporation (NASDAQ:PAHC) major shareholder Bfi Co., Llc sold 48,000 shares of the business’s stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $34.82, for a total transaction of $1,671,360.00. Following the completion of the sale, the insider now directly owns 96,000 shares of the company’s stock, valued at $3,342,720. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Shares of Phibro Animal Health Corporation (NASDAQ PAHC) opened at 36.55 on Tuesday. Phibro Animal Health Corporation has a 12 month low of $17.96 and a 12 month high of $36.95. The stock has a 50 day moving average of $33.94 and a 200 day moving average of $29.67. The stock has a market cap of $1.45 billion, a PE ratio of 22.70 and a beta of 1.35.

Phibro Animal Health Corporation (NASDAQ:PAHC) last issued its quarterly earnings data on Monday, May 8th. The company reported $0.37 earnings per share for the quarter, hitting the consensus estimate of $0.37. The business had revenue of $190 million during the quarter, compared to the consensus estimate of $185.90 million. Phibro Animal Health Corporation had a net margin of 8.49% and a return on equity of 54.68%. The company’s revenue was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.38 EPS. On average, equities analysts anticipate that Phibro Animal Health Corporation will post $1.45 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 22nd. Stockholders of record on Wednesday, May 31st will be issued a $0.10 dividend. The ex-dividend date of this dividend is Friday, May 26th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.09%. Phibro Animal Health Corporation’s payout ratio is 24.69%.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.dailypolitical.com/2017/06/20/insider-selling-phibro-animal-health-corporation-pahc-major-shareholder-sells-1671360-00-in-stock.html.

PAHC has been the subject of several research reports. Zacks Investment Research raised shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price objective for the company in a research report on Thursday, May 11th. Credit Suisse Group cut shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and boosted their price objective for the company from $29.00 to $36.00 in a research report on Friday, June 2nd. Finally, BidaskClub cut shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, June 14th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the company’s stock. Phibro Animal Health Corporation has a consensus rating of “Hold” and an average target price of $30.33.

Several institutional investors have recently made changes to their positions in the stock. Goldman Sachs Group Inc. boosted its position in shares of Phibro Animal Health Corporation by 14.6% in the first quarter. Goldman Sachs Group Inc. now owns 64,096 shares of the company’s stock worth $1,801,000 after buying an additional 8,157 shares during the last quarter. Tudor Investment Corp ET AL boosted its position in shares of Phibro Animal Health Corporation by 66.2% in the first quarter. Tudor Investment Corp ET AL now owns 16,171 shares of the company’s stock worth $454,000 after buying an additional 6,444 shares during the last quarter. AQR Capital Management LLC boosted its position in shares of Phibro Animal Health Corporation by 50.4% in the first quarter. AQR Capital Management LLC now owns 78,343 shares of the company’s stock worth $2,201,000 after buying an additional 26,244 shares during the last quarter. Gotham Asset Management LLC acquired a new position in shares of Phibro Animal Health Corporation during the first quarter worth approximately $655,000. Finally, Highbridge Capital Management LLC acquired a new position in shares of Phibro Animal Health Corporation during the first quarter worth approximately $252,000. 47.60% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.